Abstract:Glioma is the world's commonest primary brain malignancy with much of its biology relating to translational and post-translational events still unknown. In this study, we investigated the clinicopathological significance of N-linked β1-6-GlcNAc branches and GnT-V enzyme in the development and progression of astrocytic glioma. Expression of GnT-V and its GlcNAc-β1-6 oligosaccharides by-product together with Con-A binding sugars were assessed immunohistochemically on tissue microarrays of 16 normal brain and 159 tissue samples of astrocytomas of variable grades and histology. Although tissues of both grade I astrocytomas and normal brain showed considerably higher GnT-V expression, GlcNAc-β1-6 expression was significantly high only in tissues of grade I astrocytomas (p < 0.001), which is attributable to elevated levels of the precursor Con-A binding sugar moieties (p < 0.001). The activity of GnT-V enzyme was found to be dependent on the degree of glioma pathogenesis, as the GlcNAc-β1-6 branched expression diminished with every progressive grade of glioma, reaching minimum in glioblastoma (p < 0.001). Having biphasic activity in gliomagenesis, the role of GnT-V in glioma was deciphered by generating different ectopic GnT-V expressions in U-87 cells, which showed the highest GnT-V expression among selected glioma cell lines. Transient GnT-V rescue was achieved in knockdown clones by transfection with GnT-V expression vector. Suppression of GnT-V in U-87 cells slowed cell proliferation with G0/G1 cell cycle phase arrest. Reduced tumorigenicity, invasiveness and cell-ECM interactions were also associated with suppressed in vitro GnT-V activity suggesting GnT-V may act as an oncoprotein. We report for the first time that GnT-V products are involved in early gliomagenesis but their reduced expression, correlating with low Con-A binding sugars level found in high tumor grades predicts the loss of total N-glycosylation in glioma development and may be of potential diagnostic and/or prognostic value in astrocytoma.

β1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma

Beta1,4-galactosyltransferase V A growth regulator in glioma.

Beta 1,4-Galactosyltransferase V Regulates Self-Renewal of Glioma-Initiating Cell

Β1,4-Galactosyltransferase V Activates Notch1 Signaling in Glioma Stem-Like Cells and Promotes Their Transdifferentiation into Endothelial Cells

Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line.

Over-expression of ?-1,4-galactosyltransferase I, II, and V in Human Astrocytoma

Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma.

Mucin O-glycosylating Enzyme GALNT2 Facilitates the Malignant Character of Glioma by Activating the EGFR/PI3K/Akt/mTOR Axis.

Upregulated β1-6 branch N-glycan marks early gliomagenesis but exhibited biphasic expression in the progression of astrocytic glioma.

Down-regulation of the Expression of Β1,4-Galactosyltransferase V Promotes Integrin Β1 Maturation

C1GALT1 high expression enhances the progression of glioblastoma through the EGFR-AKT/ERK cascade

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

β1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLCγ-PKC pathways

B4GALT3 Promotes Cell Proliferation and Invasion in Glioblastoma

Elevated β1,4-Galactosyltransferase I in Highly Metastatic Human Lung Cancer Cells: IDENTIFICATION OF E1AF AS IMPORTANT TRANSCRIPTION ACTIVATOR

Expression of Β 1,4-Galactosyltransferase Mrna in Human Astrocytomas

Evaluation of ST6Gal1 expression and clinicopathological significance in human glioma

Down-regulation of β1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells

Role of Glycosyltransferase PomGnT1 in Glioblastoma Progression.

Galunisertib Inhibits Glioma Vasculogenic Mimicry Formation Induced by Astrocytes

High expression of GALNT7 promotes invasion and proliferation of glioma cells